Considering that the polymorphic nature of the human MHC presents a challenge for the translation of antigen-specific targeting strategies into humans, we also investigated whether Greek patients diagnosed with MS with diverse HLA-DRB1 genotypes can be screened for their T cell responses to disease-associated myelin peptides for the purposes of patient selection and stratification in future clinical trials. Here, HLA-C is linked to myeloid sarcoma.